Skip to main content

Drug Interactions between elivaldogene autotemcel and TheraCys

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

BCG elivaldogene autotemcel

Applies to: TheraCys (bcg) and elivaldogene autotemcel

If you are currently being treated or have been treated with elivaldogene autotemcel within the last couple of years, you should let your doctor know before receiving BCG. Depending on the level of your immune recovery, you may be at risk for developing an infection from BCG or have a reduced response to it. In some situations, your doctor may want to delay administration of BCG to give your body time to recover from the effects of elivaldogene autotemcel therapy. Conversely, if you have recently received BCG, your doctor may choose to postpone treatment with elivaldogene autotemcel for at least 6 weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer